Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid Dosage Regimens in Cardiac Surgery
NCT07164300Recruiting
- Sponsor
- University of Ioannina
- Start
- May 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tranexamic acid in postoperative hemorrhage (3 arms), sponsored by University of Ioannina. Primary endpoints: Duration of inhibition of fibrinolysis as measured by the ClotPro-TPA test up to 240 hours and Tranexamic blood concentration up to 240 hours. Started May 2024; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT07164300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07164300.